|
 Remidio Innovative Solutions has won First Place under the Point of Care Devices category at the Andhra Pradesh MedTech Innovation Challenge, announced at the programme's grand finale today during the AI-Driven Health Systems: Strategic Stakeholder Engagement Workshop and MedTech Innovation Challenge Grand Finale, held at the Ratan Tata Innovation Hub (RTIH), Mangalagiri, in the Amaravati capital region.
The recognition follows the deployment of Remidio's InstaEyeClinic Kit at Government Medical College and Hospital (GMCH), Guntur, where AI-enabled portable eye screening was run inside a government hospital by paramedical staff, with no ophthalmologist on site.
The InstaEyeClinic Kit combines three handheld devices, a fundus camera, a portable slit lamp and an autorefractometer, with Remidio's offline MediosHI AI in a single battery-operated carrycase. It screens for conditions like diabetic retinopathy, glaucoma, age-related macular degeneration, cataract and refractive error, in under ten minutes per patient, with AI results delivered on-device and without an internet connection.
Over seven active screening weeks from February 9 to March 30, 2026), the pilot completed 339 retinal examinations, 213 anterior-segment exams and 489 refraction tests, operated entirely by GMCH paramedical staff. The AI flagged 22 diabetic retinopathy, 10 macular degeneration and 6 glaucoma cases, generating 38 referrals into the hospital's ophthalmology OPD. The macular degeneration cases were the first ever screened for at the facility.
At the workshop, Dr. Anand Sivaraman, director and CEO of Remidio, presented "Oculomics for the Next Billion: How an AI-enabled Retinal Camera can Revolutionise Health Intelligence," on using the retina as a non-invasive window for earlier detection and population-scale health intelligence.
The MedTech Innovation Challenge is an Andhra Pradesh government initiative run through the Ratan Tata Innovation Hub. Eighteen startups ran live pilots in government hospitals across four categories, collectively serving close to 15,000 patients over the programme window under clinical supervision. Winners were selected by the Committee for Applied Technologies in Health (CATH) on the strength of real-world clinical outcomes, with total cash incentives of Rs. 40 lakh across the winning startups.
|